Episode 37 - John Mumm, CEO & Co-Founder of Deka Biosciences

Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry.

I’m joined by John Mumm, CEO of Deka Biosciences—a company breaking new ground in cytokine therapies for cancer and inflammatory diseases.

John is a true veteran of biotech, with over 30 years of experience in immunotherapy research. He’s spent his career working to unlock the potential of IL-10 and cytokines, tackling one of drug development’s biggest challenges. After leadership roles at MedImmune, and ARMO BioSciences, he founded Deka to bring a fresh approach to cytokine-based treatments.

Today, we dive into John’s journey as a three-time biotech founder, the fast-moving progress at Deka, and why cytokines have been so tough to crack—until now. Plus, we get into mindset, motivation, and what it takes to build a company that lasts.

Enjoy and Stay Tuned.